Merck, Inc.

πŸ‡΅πŸ‡­Philippines
Ownership
Subsidiary
Employees
-
Market Cap
$295.3B
Website
http://www.merck.ph

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)

First Posted Date
2004-04-16
Last Posted Date
2015-04-15
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
110
Registration Number
NCT00081510

Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)

First Posted Date
2004-02-06
Last Posted Date
2017-05-09
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
95
Registration Number
NCT00076856

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Phase 2
Completed
Conditions
First Posted Date
2004-02-06
Last Posted Date
2015-01-13
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
55
Registration Number
NCT00076869

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

Phase 2
Completed
Conditions
First Posted Date
2003-12-16
Last Posted Date
2015-07-24
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
512
Registration Number
NCT00074529

Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)

First Posted Date
2003-11-24
Last Posted Date
2015-04-21
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
15
Registration Number
NCT00073450

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2003-05-12
Last Posted Date
2015-08-27
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
46
Registration Number
NCT00060632

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2003-05-12
Last Posted Date
2015-08-27
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
33
Registration Number
NCT00060645
Locations
πŸ‡ΊπŸ‡Έ

Cancer Therapy and Research Center, University of Texas Health Center at San Antonio, San Antonio, Texas, United States

Β© Copyright 2024. All Rights Reserved by MedPath